FDA Tempers Viibryd Expectations in Journal Article

When the U.S. Food and Drug Administration approved vilazodone hydrochloride, marketed as Viibryd, for major depressive disorder (MDD) in January 2011, the approval was greeted with enthusiasm by patients, physicians ...
Comments : 0

Obama Takes Executive Action on Drug Shortages

President Barack Obama says the nation can't wait for Congress to act on drug shortages. He will sign an executive order today directing the U.S. Food and Drug Administration (FDA) ...
Comments : 0

Analysis of Flu Vaccines Finds Effectiveness Falls Short of Claims

New research published in The Lancet Infectious Diseases says most of the published studies vastly over-estimated the benefits of influenza vaccines. University of Minnesota infectious disease expert Michael Osterholm and ...
Comments : 0

Infectious Disease Experts Analyze Physician Views on Vaccines

A pair of studies presented October 20 at the Infectious Diseases Society of America annual meeting in Boston took a close look at how physicians views on vaccines may be ...
Comments : 0

Harvard Medical School to Apply Systems Approach to Drug Discovery

While the cost of drug discovery has soared, the number of new drugs brought to patients has been in decline. Can drug R&D be made faster, less expensive and more ...
Comments : 0